Patent · US Expired

Immunogobulin conjugates

US5798097A · kind A · utility

13Cited by

3References

12Claims

0Family size

Assignee

Pharmacia & Upjohn S.p.A. · IT

Inventors

Ian F. C. McKenzie · Brunswick, AU
Geoffrey Allan Pietersz · Melbourne, AU
Mark Smyth · Melbourne, AU

Key dates

Filing date	Apr 11, 1995
Grant date	Aug 25, 1998
Priority date	—
Expiry date	Apr 11, 2015

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P35/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Immunoglobulin conjugates, comprising idarubicin (Ida) conjugated to a monoclonal antibody or fragment thereof comprising at least one of the antigen binding sites of the antigen, are useful for treating a human or other animal suffering from a cancer or for depleting a subset of T lymphocytes from a population of cells.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.